University of California San Francisco
About UCSFUCSF Medical Center
Home > Doctors > Diane Wara

Diane Wara, MD

Pediatric immunologist

Dr. Diane Wara is program director of the Pediatric Clinical Research Center at UCSF Benioff Children's Hospital. She is an expert on abnormalities of the immune system in children with a primary interest in HIV/AIDS, and has published extensively in this area.

In 1991, Wara became the first associate dean for women at a United States medical school. At UCSF, she is the associate dean for minority and women's affairs. She has received numerous honors including the Eleanor Roosevelt Cancer Fellowship from the American Cancer Society and election to the Institute of Medicine. She earned her medical degree from the University of California, Irvine and completed a residency in pediatrics and a fellowship in pediatric immunology and rheumatology at UCSF. Wara is professor emeritus in the Allergy, Immunology and Blood and Marrow Transplant Division.

Clinics

HIV/AIDS Treatment Center
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337
Fax: (415) 502-2107

Immunology Center
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337

More about Diane Wara

Education

UC Irvine School of Medicine 1969

Residencies

UCSF Medical Center, Allergy/Immunology 1974

Fellowships

UCSF Medical Center, Rheumatology 1974

Selected Research and Publications

  1. Rutar T, Youm J, Porco T, Tilton N, Muskat M, McNamara N, Wara D. Ophthalmic manifestations of perinatally acquired HIV in a US cohort of long-term survivors. Br J Ophthalmol. 2015 May; 99(5):650-3.
  2. Thomas MR, Wara D, Saxton K, Truskier M, Chesney MA, Boyce WT. Family adversity and autonomic reactivity association with immune changes in HIV-affected school children. Psychosom Med. 2013 Jul-Aug; 75(6):557-65.
  3. Wilson LS, Hensic L, Paoli CJ, Basu R, Christenson M, Moskowitz JT, Wara D. The effect of prophylaxis on pediatric HIV costs. AIDS Care. 2012; 24(1):108-18.
  4. Ma CA, Wang HY, Temmerman S, Zhao Y, Wu L, Hornung RL, Wara D, Jain A. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity. Hum Mutat. 2011 Mar; 32(3):318-24.
  5. Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):189-96.
  6. Wilson LS, Basu R, Christenson M, Hensic L, Paoli C, Wara D, Moskowitz JT. Pediatric HIV costs across three treatment eras from 1986 to 2007. Pediatrics. 2010 Sep; 126(3):e541-9.
  7. Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, McCune JM, Wara DW. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol. 2009 Jul; 132(1):124-31.
  8. Butensky James E, Harmatz P, Lee M, Kennedy C, Petru A, Wara D, Miaskowski C. Altered iron metabolism in children with human immunodeficiency virus disease. Pediatr Hematol Oncol. 2009 Mar; 26(2):69-84.
  9. Milojevic D, Nguyen KD, Wara D, Mellins ED. Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol Online J. 2008 Dec 01; 6:20.
  10. Tremoulet AH, Capparelli EV, Patel P, Acosta EP, Luzuriaga K, Bryson Y, Wara D, Zorrilla C, Holland D, Mirochnick M. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants. Antimicrob Agents Chemother. 2007 Dec; 51(12):4297-302.
  11. Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, Wara D, Van Dyke R. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J Allergy Clin Immunol. 2007 Jun; 119(6):1538-41.
  12. Hecht JH, Glenn OA, Wara DW, Wu YW. JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. Pediatr Neurol. 2007 Mar; 36(3):186-9.
  13. Unadkat JD, Wara DW, Hughes MD, Mathias AA, Holland DT, Paul ME, Connor J, Huang S, Nguyen BY, Watts DH, Mofenson LM, Smith E, Deutsch P, Kaiser KA, Tuomala RE. Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother. 2007 Feb; 51(2):783-6.
  14. Taylor Z, Butani L, Blumberg D, Cowan M, Wara D, Gopal S, Gavrilita C, Da-Silva S. Index of suspicion. Pediatr Rev. 2006 Dec; 27(12):463-9.
  15. Zhang H, Schaff UY, Green CE, Chen H, Sarantos MR, Hu Y, Wara D, Simon SI, Lowell CA. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity. 2006 Aug; 25(2):285-95.
  16. Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis. 2006 Jan 15; 193(2):302-11.
  17. Chan B, Wara D, Bastian J, Hershfield MS, Bohnsack J, Azen CG, Parkman R, Weinberg K, Kohn DB. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). Clin Immunol. 2005 Nov; 117(2):133-43.
  18. Cohan D, Feakins C, Wara D, Petru A, McNicholl I, Schillinger D, Lu J, Kuritzkes D, Deeks SG. Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen. AIDS. 2005 Jun 10; 19(9):989-90.
  19. von Scheven E, Lu TT, Emery HM, Elder ME, Wara DW. Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability. Arthritis Rheum. 2003 Dec 15; 49(6):862-5.
  20. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003 Nov; 112(5):973-80.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.